• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经验加权贝叶斯容忍区间

Empirical weighted Bayesian tolerance intervals.

作者信息

Tran Hong

机构信息

Product Quality Management, Janssen Pharmaceuticals, Titusville, New Jersey, USA.

出版信息

J Biopharm Stat. 2021 Mar;31(2):180-190. doi: 10.1080/10543406.2020.1814801. Epub 2020 Sep 30.

DOI:10.1080/10543406.2020.1814801
PMID:32997587
Abstract

Bayesian statistics has been widely utilized as an approach that can incorporate prior knowledge into statistical inference. Tolerance intervals (TI) are the most commonly used statistical methods for product quality assurance. There are two main Bayesian approaches for calculating statistical tolerance intervals: Hamada and Wolfinger. A simulation-based approach was implemented to compare two-sided Wolfinger, Hamada, and frequentist tolerance intervals which control the probability content at a specified level of confidence. As sample sizes increase, compared to frequentist, Hamada TI become more conservative while Wolfinger TI are more liberal. To address this issue, we propose an empirical weighted Bayesian TI approach that is a compromise between Hamada and Wolfinger approaches. The proposed Bayesian TI result in narrower limits in certain scenarios while ensuring the confidence content coverage remains comparable to frequentist.

摘要

贝叶斯统计作为一种能够将先验知识纳入统计推断的方法,已被广泛应用。公差区间(TI)是产品质量保证中最常用的统计方法。计算统计公差区间主要有两种贝叶斯方法:滨田法和沃尔芬格法。实施了一种基于模拟的方法来比较双侧沃尔芬格法、滨田法和频率论者公差区间,这些方法在指定的置信水平下控制概率内容。随着样本量的增加,与频率论者相比,滨田公差区间变得更加保守,而沃尔芬格公差区间则更加宽松。为解决这一问题,我们提出了一种经验加权贝叶斯公差区间方法,该方法是滨田法和沃尔芬格法之间的一种折衷。所提出的贝叶斯公差区间在某些情况下会产生更窄的界限,同时确保置信内容覆盖率与频率论者相当。

相似文献

1
Empirical weighted Bayesian tolerance intervals.经验加权贝叶斯容忍区间
J Biopharm Stat. 2021 Mar;31(2):180-190. doi: 10.1080/10543406.2020.1814801. Epub 2020 Sep 30.
2
Likelihood-based random-effects meta-analysis with few studies: empirical and simulation studies.基于似然比的小样本随机效应荟萃分析:实证和模拟研究。
BMC Med Res Methodol. 2019 Jan 11;19(1):16. doi: 10.1186/s12874-018-0618-3.
3
Frequentist and Bayesian tolerance intervals for setting specification limits for left-censored gamma distributed drug quality attributes.左删失伽马分布药物质量属性设定规范限的频率派和贝叶斯容忍区间。
Pharm Stat. 2024 Mar-Apr;23(2):168-184. doi: 10.1002/pst.2344. Epub 2023 Oct 23.
4
Sample size estimation in single-arm clinical trials with multiple testing under frequentist and Bayesian approaches.在频率主义和贝叶斯方法下具有多重检验的单臂临床试验中的样本量估计。
J Biopharm Stat. 2012;22(4):819-35. doi: 10.1080/10543406.2012.676585.
5
Frequentist performances of Bayesian prediction intervals for random-effects meta-analysis.贝叶斯预测区间在随机效应荟萃分析中的频繁主义表现。
Biom J. 2021 Feb;63(2):394-405. doi: 10.1002/bimj.201900351. Epub 2020 Nov 9.
6
Simple Approach to Calculate Random Effects Model Tolerance Intervals to Set Release and Shelf-Life Specification Limits of Pharmaceutical Products.计算随机效应模型耐受区间以设定药品放行和保质期规格限度的简易方法。
PDA J Pharm Sci Technol. 2019 Jan-Feb;73(1):39-59. doi: 10.5731/pdajpst.2018.008839. Epub 2018 Oct 25.
7
Empirical Bayes interval estimates that are conditionally equal to unadjusted confidence intervals or to default prior credibility intervals.经验贝叶斯区间估计在条件上等同于未调整的置信区间或默认的先验可信区间。
Stat Appl Genet Mol Biol. 2012 Feb 21;11(3):Article 7. doi: 10.1515/1544-6115.1765.
8
A tolerance interval approach for assessment of agreement with left censored data.一种用于评估与左删失数据一致性的容忍区间方法。
J Biopharm Stat. 2007;17(4):583-94. doi: 10.1080/10543400701329430.
9
Interval estimation of a population mean using existing knowledge or data on effect sizes.利用已有关于效应量的知识或数据进行总体均数的区间估计。
Stat Methods Med Res. 2019 Jun;28(6):1703-1715. doi: 10.1177/0962280218773537. Epub 2018 May 8.
10
Using tolerance intervals for assessment of pharmaceutical quality.使用公差区间评估药品质量。
J Biopharm Stat. 2015;25(2):317-27. doi: 10.1080/10543406.2014.972512.